跳到主要內容

Cormorant Asset Management, LP 的 Form 4 申報

Ambrx Biopharma, Inc.(AMAM),2023/4/20 申報

申報編號
0000929638-23-001211
申報時間
2023/4/20 18:04 ET
交易日
2023/4/18-4/20
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $5,895 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Cormorant Asset Management, LPCIK 0001583977持股 10% 以上大股東
Chen BihuaCIK 0001599214持股 10% 以上大股東
Cormorant Global Healthcare Master Fund, LPCIK 0001618442持股 10% 以上大股東
Cormorant Private Healthcare Fund III LPCIK 0001817320持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/4/18Ordinary SharesP買進取得+3,376,646$11.27F1+$38,053,112.165,474,542間接
2023/4/19Ordinary SharesP買進取得+951,909$11.15F4+$10,612,357.4966,426,451間接
2023/4/20Ordinary SharesP買進取得+886,634$11.60F6+$10,285,220.3967,313,085間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents the weighted average sale price of American Depository Shares ("ADS") purchased in a series of open market transactions on the transaction date at prices ranging from $10.73 to $11.45 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by Fund III (as defined below).

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents the weighted average sale price of ADS purchased in a series of open market transactions on the transaction date at prices ranging from $10.87 to $11.50 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commissioner, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by Fund III.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents the weighted average sale price of ADS purchased in a series of open market transactions on the transaction date at prices ranging from $11.45 to $11.65 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commissioner, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by Fund III.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)